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CI 1.5—5.5, p < 0.02). Risk of acquiring HCV infection was
found to be 1.8 times more among FSWs who had any one
STI and practiced anal sex (p≥ 0.05) and the risk increased
12.8 times in the presence of injecting drug use (p≤ 0.05).
Within the control group, HCV antibody was present in only
1% of antenatal mothers in monogamous relationship and in
0.2% of blood donors in the region.
Conclusion: HCV antibody was found among FSWs in the
absence of the established risk factors known for transmit-
ting HCV infection. Strong association with HIV and HSV-2
indicate that the presence of these infections along with
other risk factors facilitate sexual transmission of HCV in
this setting.
doi:10.1016/j.ijid.2008.05.1096
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Background: Hepatitis C virus (HCV) genotypes and sub-
types are distributed differently in different parts of the
world. HCV genotype information is important because it
can be used as a predictor of treatment response and out-
come. In this study we evaluated the genotypes of patients
with HCV in a Greek hospital.
Methods: Specimens from 61 patients (35 males and 26
females) with HCV were tested. HCV RNA viral load was
determined by PCR (Cobas AmplicorTM HCV Monitor v2.0,
Roche Molecular Diagnostics). HCV genotype and subtype
were determined by direct sequencing of the 5′ NC gene
fragment (TrugeneTM HCV 5′ NC Genotyping Kit, Siemens
Healthcare Diagnostics)
Results: Genotype 1 was present in 21 patients with most
common subtype 1b (16/21), while genotype 3 was present
in 24 patients with most common subtype 3a (23/24). Geno-
type 2 was present in 8 patients, genotype 4 in 7 and
genotype 5 in 1. In males genotype 3 was the most frequent
(19/35), while in females genotype 1 (13/26). Genotype 3
was the most frequent (43%) in patients younger than 50
years, while genotype 1 was the most frequent (47%) in those
older than 50 years. Twenty-one patients had a baseline high
viral load (above 800,000 IU/ml): six with genotype 1b, two
with 1a, ﬁve with 2, seven with 3a and one with genotype
4. High baseline viral load was observed in 37% of patients
aged less than 50 years and 42% aged over 50 years.
Conclusion: Genotypes 1 and 3 had almost equal dis-
tribution and represent together 73% among the study
population. Genotype 1 was more frequent in older patients
and genotype 3 among younger patients.
doi:10.1016/j.ijid.2008.05.1097
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Background: Chronic hepatitis B is a public health prob-
lem in China, till to now few data are available to deﬁne
psychological state of those patients, which is extremely
important to provide psychological support for them. The
aim of the study was to explore the anxiety status and inﬂu-
encing factors in patients with chronic hepatitis B for the
purpose of providing theoretical evidences to psychological
nursing.
Methods: Sixty-seven patients with chronic hepatitis B
from the First Afﬁliated Hospital of Medical College of Xa’an
JiaoTong University from June to December in 2006 were
enrolled to complete State-Trait Anxiety Inventory (STAI)
questionnaire and questionnaire of own designing; the items
include name, sex, age, occupation, course of disease, eco-
nomic position, marital status and education.
Result: Statistic analysis indicated that state anxiety and
trait anxiety of patients with chronic hepatitis B show signif-
icant increasing in comparison with Chinese average level,
SA: 42.70± 10.32, the male SA: 42.17± 10.27 (P = 0.04),
the female SA: 44.05± 10.33 (P = 0.02); TA: 44.03± 9.17,
the male TA: 43.81± 8.61 (P = 0.028), the female TA:
46.06± 8.79 (P = 0.02). Factors associated with SA include
age (P = 0.036), occupation (P = 0.034), economic position
(P = 0.000), level of received education (P = 0.001); factors
associated with of TA include marital status (P = 0.023),
economic position (P = 0.000), level of received education
(P = 0.044).
Conclusion: SA and TA are very widespread in clinic
hepatitis B patients, the common factors include age, occu-
pation, economic position, level of received education,
marital status. It is necessary for nurses to know about
patients’ psychological status and provide targeted care to
them according to inﬂuencing factors.
doi:10.1016/j.ijid.2008.05.1098
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Background: Chronic hepatitis B is a public health
problem in China, HBV infection results in approximately
280 thousand deaths per year, mainly caused by chronic
hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).
Accumulating evidence has linked psychological factors to
the onset, progression, and outcome of chronic and latent
viral infection. Psychological factors modulate immune sys-
tem by initiating neuroimmune axis responses. Thus, we
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examined the association between the immune status and
the psychological (perceived) stress in patients with chronic
hepatitis B, and the involvement of cortisol.
Methods: Forty patients with chronic hepatitis B com-
pleted the Perceived Stress Scale-14 (PSS-14) and State-Trait
Anxiety Inventory (STAI-Form). These two scales are self-
report questionnaires to measure psychological stress, state
anxiety and trait anxiety. We measured two types of T cell-
derived cytokines level (IL-10 and IFN) and plasma cortisol.
Correlation analysis was employed to explore the relation-
ship among psychological scores, cortisol and cytokine level.
Results: Our results show that the level of IL-10 was
related to psychological stress (P = 0.03), state anxiety
(P = 0.01) and trait anxiety (P = 0.03). No correlations were
found between psychological stress and IFN-  levels. Also
no correlations were developed between cortisol and psy-
chological stress, anxiety, IL-10, and IFN- .
Conclusion: From the results, it can be concluded that
psychological stress depresses the immune reaction in
patients with chronic hepatitis B, which is disadvantage
of HBV r esolve. Those patients were in great need of
psychological support. Cortisorl plays little role between
psychological stress and immune state in patient with hep-
atitis B.
doi:10.1016/j.ijid.2008.05.1099
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Objective: Hepatitis B virus (HBV) infection is a major
public health problem worldwide. The mechanism of sus-
ceptibility to chronic persistent HBV infection is not well
clariﬁed, while the outcome of HBV infection mainly
depends on the host immune response. Different HLA class
I and II alleles may play roles in HBV infection outcome. In
this study, the association between HBV infection and HLA
alleles was studied.
Methods: HLA-A, B and DRB1 alleles in 33 patients with
chronic hepatitis B and 31 healthy carriers collapsed as
persistent group, and 30 subjects who had spontaneously
recovered from HBV infection were analyzed by using PCR-
sequence speciﬁc primer (PCR-SSP) technique
Results: The frequency of HLA-A*33 allele was higher in
persistent group than recovered group (P < 0.008); the fre-
quency of DRB1*13 allele was lower in persistent group than
in recovered group (P < 0.03). The frequency of B*52 allele
was higher in CHB patients than healthy carriers (P < 0.05).
Conclusion: HLA-A*33 was related with susceptibility and
HLA-DRB1*13 was related with protection against persis-
tency of hepatitis B. Our survey also showed that the
frequency of B*52 allele was higher in CHB patients than
healthy carriers which further conﬁrmed the role of HLA
alleles in clinical presentations of HBV infection. The above
results suggest that host HLA class I and II alleles are
important factors in determination of the outcome of HBV
infection.
doi:10.1016/j.ijid.2008.05.1100
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Objective: Hepatitis B (HB) vaccine is effective in produc-
ing protection against HB virus infection in hemodialysis (HD)
patients, but the persistence of immunity remains largely
unknown. In this study we aimed to evaluate the persistence
of hepatitis B vaccine immunity in HD patients.
Methods: In this study we had followed 54 HD patients up
to 1 year after primary hepatitis B vaccination [four doses
vaccination schedule 40g injections intramuscularly in the
deltoid muscle at 0,1,2,6 months] to evaluate the persis-
tence of immunity [as indicated by serum levels of antibody
to hepatitis B surface antigen (anti-HBs) higher than or equal
to 10 IU/l]
Results: At 1 year after vaccination, 18.18% of patients
had lost their anti-HBs (transient responders) while 81.82%
of them had detectable antibody in the serum (persistent
responders). From 81.82% of persistent responders 11.5%
and 88.5% were weak and high responders respectively.
There was no signiﬁcant difference between persistent
and transient responders regarding age, sex and nutritional
factors (serum albumin, triglycerides, and cholesterol),
hemoglobin, parathyroid hormone (PTH), fasting blood sugar
(FBS), C3, C4 and anti-HCV.
Conclusion: Our study supported this fact that an anti-
body titer above 100 IU/l following primary vaccination is
necessary in order to maintain that level of antibody 1 year
later.
doi:10.1016/j.ijid.2008.05.1101
